InvestorsHub Logo
Followers 664
Posts 46911
Boards Moderated 2
Alias Born 03/30/2009

Re: None

Thursday, 07/31/2014 1:34:07 PM

Thursday, July 31, 2014 1:34:07 PM

Post# of 48316
I just spoke to Punit and here are some of the points he mentioned:

-- Starting in September, and continuing through the fall, there will be some significant developments and milestones met.

-- They will be expanding their R&D efforts and hiring people of the same caliber as Dr. Pierce.

-- Fundamentally, OncoSec is sound. The whole sector has been taking a hit ever since Janet Yellin mentioned something about biotech being in a bubble.

-- They are not writing off Neopulse but will focus all of their efforts on Immunopulse. If they did move forward with Neopulse at this time, it would negatively impact Immunopulse and Punit intends that OncoSec be THE leader in Immunopulse.

--OncoSec will continue to focus on converting non-responders into responders (IMO, this might be their "niche").

$ONCS

Saving up your money for a rainy day,
Giving all your clothes to charity.
Last night the wife said,
"Oh boy, when you're dead
You don't take nothing with you
But your soul - think!"

(Lennon/McCartney, "The Ballad of John and Yoko")